Publicacións nas que colabora con Luis Pérez de Llano (39)

2024

  1. Basic host response parameters to classify mortality risk in COVID-19 and community-acquired pneumonia

    Scientific reports, Vol. 14, Núm. 1, pp. 12726

2023

  1. Nocturnal Dyspnea During Severe Exacerbations Is Associated With Mortality Risk in COPD

    Respiratory care, Vol. 68, Núm. 3, pp. 413-416

2022

  1. Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis

    Archivos de Bronconeumologia, Vol. 58, Núm. 3, pp. 281-283

  2. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria

    Chest, Vol. 162, Núm. 4, pp. 768-781

  3. Incidence and profile of severe exacerbations of chronic obstructive pulmonary disease due to biomass smoke or tobacco

    Annals of Thoracic Medicine, Vol. 17, Núm. 4, pp. 193-198

2021

  1. COVID-19 pneumonia in Galicia (Spain): Impact of prognostic factors and therapies on mortality and need for mechanical ventilation

    PLoS ONE, Vol. 16, Núm. 6 June

2020

  1. Factors Associated to Hospital Admission in a Care Protocol in COVID-19

    Archivos de Bronconeumologia, Vol. 56, Núm. 10, pp. 676-677

  2. Plasma Eosinophil Count and Patient-Centered Events in Chronic Obstructive Pulmonary Disease in Real-Life Clinical Practice

    Archivos de Bronconeumologia, Vol. 56, Núm. 2, pp. 129-130

  3. Regarding the role of FENO in predicting failure after ICS reduction in mild-to-moderate asthma patients

    The European respiratory journal

  4. Risk of severe COVID-19 in hypertensive patients treated with renin-angiotensin-aldosterone system inhibitors

    Medicina Clinica, Vol. 155, Núm. 11, pp. 488-490

2019

  1. Should Lung Function be Included in the Risk Stratification of Chronic Obstructive Pulmonary Disease Proposed by GesEPOC?

    Archivos de Bronconeumologia, Vol. 55, Núm. 8, pp. 436-437

2018

  1. Cardiovascular Studies in Patients with Chronic Obstructive Pulmonary Disease Due to Biomass Smoke or Tobacco

    Lung, Vol. 196, Núm. 2, pp. 195-200

  2. Octogenarian patients with chronic obstructive pulmonary disease: Characteristics and usefulness of prognostic indexes

    Medicina Clinica, Vol. 151, Núm. 2, pp. 53-58

  3. Risk Stratification in Chronic Obstructive Pulmonary Disease. Can the Spanish Guidelines be Improved?

    Archivos de Bronconeumologia, Vol. 54, Núm. 10, pp. 533-535

2017

  1. Clinical significance of the oral corticosteroid reversibility test in asthma with fixed airflow obstruction

    Archivos de Bronconeumologia

  2. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD

    International Journal of COPD, Vol. 12, pp. 2639-2646

  3. Farmer's lung disease: Analysis of 75 cases

    Medicina Clinica, Vol. 149, Núm. 10, pp. 429-435

  4. Prevalence of major comorbidities in chronic obstructive pulmonary disease caused by biomass smoke or tobacco

    Respiration, Vol. 94, Núm. 1, pp. 38-44

2016

  1. Blood Pressure Profile and Hypertensive Organ Damage in COPD Patients and Matched Controls. The RETAPOC Study

    PloS one, Vol. 11, Núm. 6, pp. e0157932

  2. ¿Son adecuados los criterios diagnósticos del fenotipo mixto EPOC-asma en la enfermedad pulmonar obstructiva crónica por humo de biomasa?

    Archivos de Bronconeumologia